About CivaTech Oncology

CivaTech Oncology was founded in 2006 to develop and market innovative low-dose-rate brachytherapy devices to treat cancer.

Our patented and patent-pending fabrication methods allow us to precisely encapsulate radioactive materials into polymer structures.

These polymer-based brachytherapy devices offer physicians treatment options for tumors that have never before been accessible with low-dose-rate brachytherapy.